Eradication therapy for Pseudomonas aeruginosa colonization episodes in cystic fibrosis patients not chronically colonized by P. aeruginosa

被引:49
作者
Schelstraete, Petra [1 ,2 ]
Haerynck, Filomeen [1 ,2 ]
Van Daele, Sabine [1 ,2 ]
Deseyne, Sarah [3 ]
De Baets, Frans [1 ,2 ]
机构
[1] Ghent Univ Hosp, Dept Pediat Pulmonol, Ghent, Belgium
[2] Ghent Univ Hosp, Cyst Fibrosis Ctr, Ghent, Belgium
[3] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium
关键词
Cystic fibrosis; Pseudomonas aeruginosa; Eradication; Therapy; CHANGING EPIDEMIOLOGY; INITIAL COLONIZATION; PULMONARY-FUNCTION; CHRONIC INFECTION; YOUNG-CHILDREN; LUNG-DISEASE; PATHOPHYSIOLOGY; TOBRAMYCIN;
D O I
10.1016/j.jcf.2012.07.008
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Pseudomonas aeruginosa (Pa) is one of the most common and clinically important pathogens in patients with cystic fibrosis (CF). Chronic Pa colonization in CF patients is associated with increased morbidity and mortality. Pa strains causing early infection are usually antibiotic sensitive and have low bacterial density in the airways. As a result, the treatment strategy has shifted from suppressive therapy in patients chronically colonized by Pa to attempts at early eradication therapy as soon as Pa is detected. In the literature, different treatment regimens have been studied. However, the optimal treatment regimen and duration of treatment are not yet determined. In this article, an overview on the natural history of early Pa colonization and the history of eradication treatment is given. Moreover, the results of the different eradication treatment trials and directions for future research are discussed. (C) 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [41] No benefit of longer eradication therapy of Pseudomonas aeruginosa primoinfections in pediatric cystic fibrosis
    F. Claude
    I. Rochat
    G. M. Hafen
    BMC Research Notes, 12
  • [42] Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment
    Valenza, Giuseppe
    Radike, Kerstin
    Schoen, Christoph
    Horn, Stephan
    Oesterlein, Anett
    Frosch, Matthias
    Abele-Horn, Marianne
    Hebestreit, Helge
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 42 (11-12) : 885 - 889
  • [43] Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis
    Langan, Katherine M.
    Kotsimbos, Tom
    Peleg, Anton Y.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (06) : 547 - 556
  • [44] Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients
    Lang, AB
    Horn, MP
    Imboden, MA
    Zuercher, AW
    VACCINE, 2004, 22 : S44 - S48
  • [45] Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis
    Iain L. Lamont
    Anna F. Konings
    David W. Reid
    BioMetals, 2009, 22 : 53 - 60
  • [46] Predictive values of antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis one year after early eradication treatment
    Kappler, Matthias
    Nagel, Felicitas
    Feilcke, Maria
    Heilig, Gabriele
    Grimmelt, Ann-Christin
    Pawlita, Ingo
    Irnstetter, Armin
    Hildebrandt, Jenna
    Burmester, Helen
    Kroener, Caroline
    Griese, Matthias
    JOURNAL OF CYSTIC FIBROSIS, 2014, 13 (05) : 534 - 541
  • [47] RISK-FACTORS FOR PSEUDOMONAS-AERUGINOSA COLONIZATION IN CYSTIC-FIBROSIS PATIENTS
    KEREM, E
    COREY, M
    STEIN, R
    GOLD, R
    LEVISON, H
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (07) : 494 - 498
  • [48] Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients
    Cantón, R
    Cobos, N
    de Gracia, J
    Baquero, F
    Honorato, J
    Gartner, S
    Alvarez, A
    Salcedo, A
    Oliver, A
    García-Quetglas, E
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (09) : 690 - 703
  • [49] Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
    Crull, Mathew R.
    Ramos, Kathleen J.
    Caldwell, Ellen
    Mayer-Hamblett, Nicole
    Aitken, Moira L.
    Goss, Christopher H.
    BMC PULMONARY MEDICINE, 2016, 16
  • [50] Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis
    Blanco-Aparicio, Marina
    Luis Saleta Canosa, Jesus
    Valino Lopez, Paz
    Martin Egana, Maria Teresa
    Vidal Garcia, Iria
    Montero Martinez, Carmen
    CHRONIC RESPIRATORY DISEASE, 2019, 16